Boston Scientific Corporation (NYSE:BSX) is one of the best high-volume stocks to invest in. On August 6, the FDA announced ...

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston Scientific told customers that its Endotak Reliance defibrillation leads with ...

Boston Scientific is recommending updates to the instructions for use to minimize the issue, which has been tied to 17 deaths ...

The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.

The update covers devices used in procedures to implant the company’s Watchman heart device.

Boston Scientific reported Q2 2025 sales of over $5bn, a 22.8% rise on Q2 2024, besting previous growth estimates of 19.5% at the high end.

On Feb. 21, Boston Scientific issued an advisory notice explaining that use of the aliquot technique is not recommended with Obsidio Embolic when used for procedures treating lower GI bleeding.

Boston Scientific has won regulatory clearance for what it says is the first disposable duodenoscope, a device inserted through the mouth so doctors can look into the small intestine. A single-use ...

NATICK, Mass., Boston Scientific Corporation's ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System have received U.S. Food and ...

Boston Scientific Corporation BSX received the FDA approval for its EXALT Model D single-use duodenoscope, which is to be used in endoscopic retrograde cholangiopancreatography (ERCP) procedures ...